|
1
|
Stewart AZ, Leach DS and Pietenpol AJ:
p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents
endoreduplication after mitotic spindle disruption. Mol Cell Biol.
19:205–215. 1999.PubMed/NCBI
|
|
2
|
Satyanarayana A, Hilton MB and Kaldis P:
p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase
DNA damage checkpoint. Mol Biol Cell. 19:65–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heasley LE and Han SY: JNK regulation of
oncogenesis. Mol Cells. 21:167–173. 2006.
|
|
4
|
Matsukawa J, Matsuzawa A, Takeda K and
Ichijo H: The ASK1-MAP kinase cascades in mammalian stress
response. J Biochem. 136:261–265. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Potapova O, Haghighi A, Bost F, Liu C,
Birrer M, Gjerset R and Mercola D: The Jun kinase/stress-activated
protein kinase pathway functions to regulate DNA repair and
inhibition of the pathway sensitizes tumor cells to cisplatin. J
Biol Chem. 272:14041–14044. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta S, Campbell D, Dérijard B and Davis
RJ: Transcription factor ATF2 regulation by the JNK signal
transduction pathway. Science. 267:389–393. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bocco JL, Bahr A, Goetz J, Hauss C,
Kallunki T, Kedinger C and Chatton B: In vivo association of ATFa
with JNK/SAP kinase activities. Oncogene. 12:1971–1980.
1996.PubMed/NCBI
|
|
8
|
Hibi M, Lin A, Smeal T, Minden A and Karin
M: Identification of an oncoprotein- and UV-responsive protein
kinase that binds and potentiates the c-Jun activation domain.
Genes Dev. 7:2135–2148. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Janknecht R and Hunter T: Convergence of
MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J.
16:1620–1627. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dhanasekaran DN and Reddy EP: JNK
signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu J and Lin A: Role of JNK activation in
apoptosis: a double-edged sword. Cell Res. 15:36–42. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parra E and Ferreira J: Knockdown of the
c-Jun-N-terminal kinase expression by siRNA inhibits MCF-7 breast
carcinoma cell lines growth. Oncol Rep. 24:1339–1345. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parra E: Activation of MAP kinase family
members triggered by TPA or ionomycin occurs via the protein
phosphatase 4 pathway in Jurkat leukemia T cells. Mol Med Rep.
5:773–778. 2012.PubMed/NCBI
|
|
14
|
Parra E: Inhibition of JNK-1 by small
interference RNA induces apoptotic signalling in PC-3 prostate
cancer cells. Int J Mol Med. 30:923–930. 2012.PubMed/NCBI
|
|
15
|
Beckmann AM and Wilce PA: EGR
transcription factors in the nervous system. Neurochem Int.
31:477–510. 1997. View Article : Google Scholar
|
|
16
|
Whitlock NC, Bahn JH, Lee SH, Eling TE and
Baek SJ: Resveratrol-induced apoptosis is mediated by early growth
response-1, Krüppel-like factor 4, and activating transcription
factor 3. Cancer Prev Res. 4:116–127. 2011.PubMed/NCBI
|
|
17
|
Eichelberger L, Koch MO, Eble JN, Ulbright
TM, Juliar BE and Cheng L: Maximum tumor diameter is an independent
predictor of prostate-specific antigen recurrence in prostate
cancer. Mod Pathol. 18:886–890. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Houston P, Campbell CJ, Svaren J,
Milbrandt J and Braddock M: The transcriptional corepressor NAB2
blocks EGR-1-mediated growth factor activation and agiogenesis.
Biochem Biophys Res Commun. 283:480–486. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Collins S, Lutz MA, Zank PE, Anders RA,
Kersh GJ and Powell JD: Opposing regulation of T cell function by
EGR-1/NAB2 and EGR-2/EGR-3. Eur J Immunol. 38:528–536. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Parra E, Ortega A and Saenz L:
Down-regulation of EGR-1 by siRNA inhibits growth of human prostate
carcinoma cell line PC-3. Oncol Rep. 22:1513–1518. 2009.PubMed/NCBI
|
|
21
|
Pignatelli M, Luna-Medina R, Pérez-Rendón
A, Santos A and Perez-Castillo A: The transcription factor early
growth response factor-1 (EGR-1) promotes apoptosis of
neuroblastoma cells. Biochem J. 373:739–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banks MF, Gerasimovskaya EV, Tucker DA,
Frid MG, Carpenter TC and Stenmark KR: EGR-1 antisense
oligonucleotides inhibit hypoxia-induced proliferation of pulmonary
artery adventitial fibroblasts. J Appl Physiol. 98:732–738. 2005.
View Article : Google Scholar
|
|
23
|
Sperandio S, Fortin J, Sasik R, Robitaille
L, Corbeil J and de Belle I: The transcription factor EGR1
regulates the HIF-1alpha gene during hypoxia. Mol Carcinog.
48:38–44. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parra E and Ferreira J: The Effect of
siRNA-EGR-1 and camptothecin on growth and chemosensitivity of
breast cancer cell lines. Oncol Rep. 22:1159–1165. 2010.PubMed/NCBI
|
|
25
|
Adamson ED and Mercola D: EGR1
transcription factor: multiple roles in prostate tumor cell growth
and survival. Tumour Biol. 23:93–102. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Catania MV, Copani A, Calogero A, Ragonese
GI, Condorelli DF and Nicoletti F: An enhanced expression of the
immediate early gene, EGR-1, is associated with neuronal apoptosis
in culture. Neuroscience. 91:1529–1538. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nair P, Muthukkumar S, Sells SF, Han S,
Sukhatme VP and Rangnekar VM: Early growth response-1-dependent
apoptosis is mediated by p53. J Biol Chem. 272:20131–20138. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calogero A, Arcella A, De Gregorio G,
Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G, et
al: The early growth response gene EGR-1 behaves as a suppressor
gene that is down-regulated independent of ARF/Mdm2 but not p53
alterations in fresh human gliomas. Clin Cancer Res. 7:2788–2796.
2001.PubMed/NCBI
|
|
29
|
Stevenson M: Therapeutic potential of RNA
interference. N Engl J Med. 351:1772–1777. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sui G, Soohoo C, Affar el B, Gay F and Shi
Y, Forrester WC and Shi Y: A DNA vector-based RNAi technology to
suppress gene expression in mammalian cells. Proc Natl Acad Sci
USA. 99:5515–5520. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Parra E, Ferreira J and Saenz L:
Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is
associated with decreased expression of AP-1 and NF-κB. Int J Mol
Med. 28:847–853. 2011.PubMed/NCBI
|
|
32
|
Ciccarelli C, Marampon F, Scoglio A, Mauro
A, Giacinti C, De Cesaris P and Zani BM: p21WAF1
expression induced by MEK/ERK pathway activation or inhibition
correlates with growth arrest, myogenic differentiation and
onco-phenotype reversal in rhabdomyosarcoma cells. Mol Cancer.
4:412005. View Article : Google Scholar
|
|
33
|
Todd DE, Densham RM, Molton SA, Balmanno
K, Newson C, Weston CR, Garner AP, Scott L and Cook SJ: ERK1/2 and
p38 cooperate to induce a p21CIP1-dependent G1 cell
cycle arrest. Oncogene. 23:3284–3295. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ragione FD, Cucciolla V, Criniti V, Indaco
S, Borriello A and Zappia V: p21Cip1 gene expression is
modulated by EGR1: a novel regulatory mechanism involved in the
resveratrol antiproliferative effect. J Bio Chem. 278:23360–23368.
2003.
|
|
35
|
Boutros T, Chevet E and Metrakos P:
Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase
regulation: roles in cell growth, death, and cancer. Pharmacol Rev.
60:261–310. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim MJ, Choi SY, Park IC, Hwang SG, Kim C,
Choi YH, Kim H, Lee KH and Lee SJ: Opposing roles of c-Jun
NH2-terminal kinase and p38 mitogen-activated protein kinase in the
cellular response to ionizing radiation in human cervical cancer
cells. Mol Cancer Res. 6:1718–1731. 2008. View Article : Google Scholar
|
|
37
|
Wu J, Sun J and Xue Y: Involvement of JNK
and P53 activation in G2/M cell cycle arrest and apoptosis induced
by titanium dioxide nanoparticles in neuron cells. Toxicol Lett.
199:269–276. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choi BH, Kim CG, Bae YS, Lim Y, Lee YH and
Shin SY: p21Waf1/Cip1 expression by curcumin in U-87MG
human glioma cells: role of early growth response-1 expression.
Cancer Res. 68:1369–1377. 2008.
|
|
39
|
Clark JA, Black AR, Leontieva OV, Frey MR,
Pysz MA, Kunneva L, Woloszynska-Read A, Roy D and Black JD:
Involvement of the ERK signaling cascade in protein kinase
C-mediated cell cycle arrest in intestinal epithelial cells. J Biol
Chem. 279:9233–9247. 2004. View Article : Google Scholar : PubMed/NCBI
|
